INDEMNIFICATION AGREEMENTIndemnification Agreement • June 13th, 2008 • Salient Surgical Technologies, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Agreement, made and entered into this day of , 2008 (“Agreement”), by and between Salient Surgical Technologies, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”):
LICENSE AGREEMENTLicense Agreement • June 13th, 2008 • Salient Surgical Technologies, Inc. • Electromedical & electrotherapeutic apparatus • Minnesota
This License Agreement is made this 9th day of August, 1999 (the “Effective Date”), by and among Virtuel Medical Devices, Inc. (“Licensee”), a Delaware corporation, and Medtronic, Inc. (“Medtronic”), a Minnesota corporation.
REFERENCE DATA LEASELease • June 13th, 2008 • Salient Surgical Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New Hampshire
This LEASE (hereinafter “Lease”), is entered into by and between 200 INTERNATIONAL LIMITED PARTNERSHIP, a Delaware limited partnership, having an address of One New Hampshire Avenue, Suite 101, Portsmouth, New Hampshire 03801 hereinafter “Sublessor”), and TISSUELINK MEDICAL, INC., a Delaware corporation, having an address as set forth in the reference data to this Lease (hereinafter “Sublessee”).
AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • June 13th, 2008 • Salient Surgical Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
SALIENT SURGICAL TECHNOLOGIES, INC. Amendment to Secured Subordinated Convertible Promissory Note and Warrant Purchase Agreement Dated: June 11, 2008Secured Subordinated Convertible Promissory Note and Warrant Purchase Agreement • June 13th, 2008 • Salient Surgical Technologies, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
Reference is made hereby to the Secured Subordinated Convertible Promissory Note and Warrant Purchase Agreement dated as of September 1, 2006 (the “Note Purchase Agreement”) by and among Salient Surgical Technologies, Inc., a Delaware corporation (the “Company”) (formerly known as TissueLink Medical, Inc.), and the Investors. All capitalized terms used herein and not separately defined shall have the meaning ascribed to them in the Note Purchase Agreement.
SALIENT SURGICAL TECHNOLOGIES, INC. Omnibus Amendment to Warrants to Purchase Shares of Series D Convertible Preferred Stock of Salient Surgical Technologies, Inc. (formerly known as TissueLink Medical, Inc.) Dated: June 11, 2008Omnibus Amendment to Warrants • June 13th, 2008 • Salient Surgical Technologies, Inc. • Electromedical & electrotherapeutic apparatus • Minnesota
Reference is made hereby to the License Agreement between Salient Surgical Technologies, Inc. (the “Company”) (formerly known as TissueLink Medical, Inc.) and Medtronic, Inc. (“Medtronic”), dated August 9, 1999 (as amended by Amendment No. 1 dated June 18, 2002, Amendment No. 2 dated March 1, 2004, Amendment No. 3 dated July 18, 2006 and Amendment No. 4 dated April 1, 2007, the “License”) and each warrant issued to Medtronic by the Company pursuant to Section 3.4 of the License (collectively, the “Warrants”). All capitalized terms used herein and not separately defined shall have the meaning ascribed to them in the Warrants.
June 10, 2008Employment Agreement • June 13th, 2008 • Salient Surgical Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New Hampshire
This Agreement between you and Salient Surgical Technologies, Inc., formerly named and known as TissueLink Medical, Inc., (the “Company”), effective as of the date first written above (the “Effective Date”), amends in part and restates that certain letter agreement of employment between you and the Company dated as of January 22, 2008, that resulted from your promotion to President and Chief Executive Officer (“CEO”) of the Company (the “Original Agreement”), as follows:
FIRST AMENDMENT TO LEASELease • June 13th, 2008 • Salient Surgical Technologies, Inc. • Electromedical & electrotherapeutic apparatus
This First Amendment (the “First Amendment”) to Lease is dated, made and effective as of May 15, 2008, by and among 200 INTERNATIONAL LIMITED PARTNERSHIP, a Delaware limited partnership, having an address at One New Hampshire Avenue, Suite 101, Portsmouth, New Hampshire 03801 (“Sublessor”) and SALIENT SURGICAL TECHNOLOGIES, INC., f/k/a TISSUELINK MEDICAL, INC., a Delaware corporation, having an address at One Washington Center, Suite 400, Dover, New Hampshire 03820 (“Sublessee”).
